Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247563.RAp_qFlMNeEEbD-Br7oD5zDNAItjRmWhZH1eUQGhz4QbM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247563.RAp_qFlMNeEEbD-Br7oD5zDNAItjRmWhZH1eUQGhz4QbM130_assertion type Assertion NP1247563.RAp_qFlMNeEEbD-Br7oD5zDNAItjRmWhZH1eUQGhz4QbM130_head.
- NP1247563.RAp_qFlMNeEEbD-Br7oD5zDNAItjRmWhZH1eUQGhz4QbM130_assertion description "[The determined specificity of the IGH assay was 84.6% in the group of lymphomas and 86.2% in the group of reactive lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247563.RAp_qFlMNeEEbD-Br7oD5zDNAItjRmWhZH1eUQGhz4QbM130_provenance.
- NP1247563.RAp_qFlMNeEEbD-Br7oD5zDNAItjRmWhZH1eUQGhz4QbM130_assertion evidence source_evidence_literature NP1247563.RAp_qFlMNeEEbD-Br7oD5zDNAItjRmWhZH1eUQGhz4QbM130_provenance.
- NP1247563.RAp_qFlMNeEEbD-Br7oD5zDNAItjRmWhZH1eUQGhz4QbM130_assertion SIO_000772 25501347 NP1247563.RAp_qFlMNeEEbD-Br7oD5zDNAItjRmWhZH1eUQGhz4QbM130_provenance.
- NP1247563.RAp_qFlMNeEEbD-Br7oD5zDNAItjRmWhZH1eUQGhz4QbM130_assertion wasDerivedFrom befree-2016 NP1247563.RAp_qFlMNeEEbD-Br7oD5zDNAItjRmWhZH1eUQGhz4QbM130_provenance.
- NP1247563.RAp_qFlMNeEEbD-Br7oD5zDNAItjRmWhZH1eUQGhz4QbM130_assertion wasGeneratedBy ECO_0000203 NP1247563.RAp_qFlMNeEEbD-Br7oD5zDNAItjRmWhZH1eUQGhz4QbM130_provenance.